Skip to content 
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Orlando, Florida. more
| Time Frame | IRMD | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -1.59% | 0.72% | -1.31% |
| 1-Month Return | -1.5% | 1.27% | 0.78% |
| 3-Month Return | 17.71% | 3.13% | 3.46% |
| 6-Month Return | 44.69% | 15.81% | 6.19% |
| 1-Year Return | 78.06% | 8.89% | 11.68% |
| 3-Year Return | 176.1% | 20.79% | 71.21% |
| 5-Year Return | 321.61% | 35.89% | 74.81% |
| 10-Year Return | 500.95% | 138.44% | 256.59% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 41.81M | 53.30M | 65.56M | 73.24M | 83.81M | [{"date":"2021-12-31","value":49.89,"profit":true},{"date":"2022-12-31","value":63.6,"profit":true},{"date":"2023-12-31","value":78.22,"profit":true},{"date":"2024-12-31","value":87.39,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 9.76M | 12.02M | 15.40M | 16.89M | 19.49M | [{"date":"2021-12-31","value":50.1,"profit":true},{"date":"2022-12-31","value":61.68,"profit":true},{"date":"2023-12-31","value":79.04,"profit":true},{"date":"2024-12-31","value":86.67,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 32.05M | 41.28M | 50.16M | 56.35M | 64.32M | [{"date":"2021-12-31","value":49.83,"profit":true},{"date":"2022-12-31","value":64.18,"profit":true},{"date":"2023-12-31","value":77.98,"profit":true},{"date":"2024-12-31","value":87.6,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 76.65% | 77.45% | 76.50% | 76.94% | 76.75% | [{"date":"2021-12-31","value":98.97,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.78,"profit":true},{"date":"2024-12-31","value":99.34,"profit":true},{"date":"2025-12-31","value":99.09,"profit":true}] |
| Operating Expenses | 22.23M | 25.65M | 30.12M | 34.39M | 38.18M | [{"date":"2021-12-31","value":58.23,"profit":true},{"date":"2022-12-31","value":67.2,"profit":true},{"date":"2023-12-31","value":78.9,"profit":true},{"date":"2024-12-31","value":90.07,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 9.82M | 15.63M | 20.04M | 21.96M | 26.15M | [{"date":"2021-12-31","value":37.55,"profit":true},{"date":"2022-12-31","value":59.77,"profit":true},{"date":"2023-12-31","value":76.63,"profit":true},{"date":"2024-12-31","value":84,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | 53.41K | 1.13M | 3.57M | 4.50M | - | [{"date":"2021-12-31","value":1.19,"profit":true},{"date":"2022-12-31","value":25.2,"profit":true},{"date":"2023-12-31","value":79.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 9.84M | 16.18M | 21.74M | 24.28M | 28.36M | [{"date":"2021-12-31","value":34.68,"profit":true},{"date":"2022-12-31","value":57.05,"profit":true},{"date":"2023-12-31","value":76.65,"profit":true},{"date":"2024-12-31","value":85.59,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | 510.82K | 3.35M | 4.55M | 5.04M | 5.88M | [{"date":"2021-12-31","value":8.69,"profit":true},{"date":"2022-12-31","value":57.02,"profit":true},{"date":"2023-12-31","value":77.29,"profit":true},{"date":"2024-12-31","value":85.72,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income After Taxes | 9.33M | 12.83M | 17.19M | 19.23M | - | [{"date":"2021-12-31","value":48.48,"profit":true},{"date":"2022-12-31","value":66.69,"profit":true},{"date":"2023-12-31","value":89.39,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 9.33M | 12.83M | 16.33M | 19.23M | - | [{"date":"2021-12-31","value":48.48,"profit":true},{"date":"2022-12-31","value":66.69,"profit":true},{"date":"2023-12-31","value":84.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 9.33M | 12.83M | 17.19M | 19.23M | 22.48M | [{"date":"2021-12-31","value":41.48,"profit":true},{"date":"2022-12-31","value":57.06,"profit":true},{"date":"2023-12-31","value":76.48,"profit":true},{"date":"2024-12-31","value":85.56,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | 0.83 | 1.09 | 1.48 | 1.61 | 1.87 | [{"date":"2021-12-31","value":44.39,"profit":true},{"date":"2022-12-31","value":58.29,"profit":true},{"date":"2023-12-31","value":79.14,"profit":true},{"date":"2024-12-31","value":86.1,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| IRMD | |
|---|---|
| ROA (LTM) | 15.78% |
| ROE (LTM) | 24.78% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| IRMD | |
|---|---|
| Trailing PE | 57.50 |
| Forward PE | 47.62 |
| P/S (TTM) | 15.27 |
| P/B | 13.43 |
| Price/FCF | 219 |
| EV/R | 14.55 |
| EV/Ebitda | 46.63 |
| PEG | 4.46 |
Iradimed Co (IRMD) share price today is $101.44
Yes, Indians can buy shares of Iradimed Co (IRMD) on Vested. To buy
Yes, you can purchase fractional shares of Iradimed Co (IRMD) via the Vested app. You can start investing in Iradimed Co (IRMD) with a minimum investment of $1.
You can invest in shares of Iradimed Co (IRMD) via Vested in three simple steps:
The 52-week high price of Iradimed Co (IRMD) is $107.9. The 52-week low price of Iradimed Co (IRMD) is $46.88.
The price-to-earnings (P/E) ratio of Iradimed Co (IRMD) is 57.5
The price-to-book (P/B) ratio of Iradimed Co (IRMD) is 13.43
The dividend yield of Iradimed Co (IRMD) is 0.71%
The market capitalization of Iradimed Co (IRMD) is $1.28B
The stock symbol (or ticker) of Iradimed Co is IRMD
Consider the share price of Iradimed Co as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Iradimed Co has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Iradimed Co shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Iradimed Co stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Iradimed Co and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Iradimed Co stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
